Key result
Primary aldosteronism is linked to a significantly blunted renin suppression during saline infusion testing.
Why the study?
Diagnostic strategies remain controversial for inconclusive saline infusion test (SIT) results, and whether changes in plasma renin activity during SIT offer diagnostic value for primary aldosteronism was unknown.
Does the change in plasma renin activity during the saline infusion test (ΔPRA) improve the diagnostic accuracy for primary aldosteronism in hypertensive patients, particularly those with inconclusive SIT results?
Cross-Sectional (n=570)
No
Does the change in plasma renin activity during the saline infusion test (ΔPRA) improve the diagnostic accuracy for primary aldosteronism in hypertensive patients, particularly those with inconclusive SIT results?
Measuring the change in plasma renin activity before and after a saline infusion test (ΔPRA) provides strong auxiliary diagnostic value for primary aldosteronism and correctly classifies 79.1% of patients with otherwise inconclusive post-SIT aldosterone levels.
Plasma renin activity change during saline infusion may aid primary aldosteronism diagnosis in inconclusive cases; hypothesis-generating pending prospective validation.
Context. Failure of plasma aldosterone suppression during the saline infusion test (SIT) confirms primary aldosteronism (PA); recommendations for diagnostic strategies are currently controversial in the case of an inconclusive test result with a post-SIT PAC 5–10 ng/dl, while the renin change during SIT is not focused by the previous study. Objective. To clarify whether it has some hidden diagnostic values for PA, especially in the case of an inconclusive SIT result, we investigated the difference in changes of plasma renin activity (PRA) during SIT between patients with PA and non-PA. Methods. We measured and compared the SIT parameters of 159 PA patients, 368 non-PA patients, and 43 inconclusive patients who were included in this study. Results. The PA group showed a minor change of PRA during the SIT (ΔPRA, defined as (pre-SIT PRA–post-SIT PRA)) compared with the non-PA group (0.17 ng/ml/h vs. 1.07 ng/ml/h, P < 0.001 ). According to ROC analysis, ΔPRA showed a greater AUC than post-SIT PRA (0.897 vs. 0.855, P < 0.001 ). The cutoff value was 0.5 ng/ml/h, with 90.3% sensitivity and 78.6% specificity. When combined with ARR post-SIT, it showed 81.6% sensitivity and 97.0% specificity for PA diagnosis. Further analysis of 43 patients with an inconclusive SIT result who completed AVS found that ΔPRA was smaller in the confirmed PA group compared with the unconfirmed PA group (0.19 ng/ml/h vs. 0.29 ng/ml/h, P < 0.05 ); there was no significant difference in PAC post-SIT between two groups. ΔPRA ≤ 0.21 ng/ml/h provides 71.4% sensitivity, 80.0% specificity, and 87.0% PPV for their PA diagnosis. Conclusions. PA patients show minor PRA change during SIT; the change of PRA during SIT provides an auxiliary diagnostic value for PA, especially in patients with an inconclusive SIT result.
No takes yet. Share an insight, caveat, or question.
Adilijiang et al. (2021) conducted a cross-sectional in Hypertension suspected of primary aldosteronism (PA) (n=570). Change in plasma renin activity during saline infusion test (ΔPRA) vs. Non-primary aldosteronism (non-PA) or post-SIT PRA / ARR parameters was evaluated on Change in plasma renin activity during the saline infusion test (ΔPRA, defined as pre-SIT PRA minus post-SIT PRA) and diagnostic accuracy for primary aldosteronism (p=<0.001). Primary aldosteronism patients exhibited a significantly smaller change in plasma renin activity during the saline infusion test than non-PA patients (0.17 vs. 1.07 ng/ml/h, P<0.001; AUC 0.897).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: